AlumiFuel Power Corp.
7315 East Peakview Avenue
Englewood,
CO 80111
United States - Map
Phone: 303-796-8940
Fax: 303-796-0335
| Inhibiton Therapeutics, Inc. focuses on the research, development, and commercialization of technologies and products for cancer therapeutic agents and cancer fighting drugs called targeted therapies. These drugs are intended to identify molecular causes of cancer and inhibit the signals that cancer cells need to multiply. The company, through its subsidiary, AlumiFuel Power Inc. (API), also generates alternative energy comprising hydrogen gas and steam for various niche applications requiring on-site, on-demand fuel sources. Its technology is based on the exothermic reaction of aluminum powder and water combined with proprietary additives, which act as catalysts, initiators, and reactants. APIs hydrogen fills inflatable devices, such as weather balloons, and hard-to-handle and high pressure K-Cylinders; and steam/hydrogen output drives turbine-based underwater propulsion systems and auxiliary power systems. Inhibiton Therapeutics, Inc. is based in Englewood, Colorado. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Henry Fong , 73
Principal Exec. Officer, Pres, Principal Financial Officer, Principal Accounting Officer |
$
96.00K | N/A | Mr. Thomas B. Olson , 43
Sec. |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-09
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.29% Nasdaq 
0.01 (5.88%) 
Profile
